Adverse pregnancy outcomes are associated with Plasmodium vivax malaria in a prospective cohort of women from the Brazilian Amazon
Open accessThe DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.
Abstract
Background: Malaria in Brazil represents one of the highest percentages of Latin America cases, where approximately 84% of infections are attributed to Plasmodium ( P . ) vivax . Despite the high incidence, many aspects of gestational malaria resulting from P . vivax infections remain poorly studied. As such, we aimed to evaluate the consequences of P . vivax infections during gestation on the health of mothers and their neonates in an endemic area of the Amazon. Methods and findings: We have conducted an observational cohort study in Brazilian Amazon between January 2013 and April 2015. 600 pregnant women were enrolled and followed until delivery. After applying exclusion criteria, 329 mother-child pairs were included in the analysis. Clinical data regarding maternal infection, newborn’s anthropometric measures, placental histopathological characteristics, and angiogenic and inflammatory factors were evaluated. The presence of plasma IgG against the P . vivax (Pv) MSP1 19 protein was used as marker of exposure and possible associations with pregnancy outcomes were analyzed. Multivariate logistic regression analysis revealed that P . vivax infections during the first trimester of pregnancy are associated with adverse gestational outcomes such as premature birth (adjusted odds ratio [aOR] 8.12, 95% confidence interval [95%CI] 2.69–24.54, p < 0.0001) and reduced head circumference (aOR 3.58, 95%CI 1.29–9.97, p = 0.01). Histopathology analysis showed marked differences between placentas from P . vivax -infected and non-infected pregnant women, especially regarding placental monocytes infiltrate. Placental levels of vasomodulatory factors such as angiopoietin-2 (ANG-2) and complement proteins such as C5a were also altered at delivery. Plasma levels of anti-PvMSP1 19 IgG in infected pregnant women were shown to be a reliable exposure marker; yet, with no association with improved pregnancy outcomes. Conclusions: This study indicates that P . vivax malaria during the first trimester of pregnancy represents a higher likelihood of subsequent poor pregnancy outcomes associated with marked placental histologic modification and angiogenic/inflammatory imbalance. Additionally, our findings support the idea that antibodies against PvMSP1 19 are not protective against poor pregnancy outcomes induced by P . vivax infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, a study conducted in Brazil by Dombrowski et al. (2021) found that IgG against the P.vivax MSP119 protein was used as a marker for exposure during pregnancy [96].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [96]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, a study conducted in Brazil by Dombrowski et al. (2021) found that IgG against the P.vivax MSP119 protein was used as a marker for exposure during pregnancy [96].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as Dombrowski et al. (2021)
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dombrowski et al. (2020) found that, in the Brazilian Amazon, plasma IgG against the MSP119 protein of P.vivax serves as a marker for infection during the first trimester of pregnancy [116].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [116]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 1×
“It is unclear whether placental vasomodulation is being promoted or inhibited in our cohort, as diminished sFlt-1 and increased sVEGFR-2 support angiogenesis and vasodilation [58], while decreased ANG-2 and increased sTIE-2 suggest an anti-angiogenic environment [59].”
BackgroundVillar, J., Ismail, L. C., Victora, C. G., Ohuma, E. O., Bertino, E., Altman, D. G., Lambert, A., Papageorghiou, A. T., Carvalho, M., Jaffer, Y. A., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60932-6 · Cited by 2,281 · cited 1×
“Small for gestational age (SGA), reduced head circumference, and reduced body length were defined as: birth weight, head circumference and length below the 10th percentile sex-specific for GA according to the INTERGROWTH-21st standards [31].”
MethodLow birthweight: country regional and global estimates.
Wardlaw, T., Blanc, A. K., Zupan, J., & Åhman, A. (2004) · Cited by 1,773
Epidemiology and burden of malaria in pregnancy
Desai, M., ter Kuile, F. O., Nosten, F., McGready, R., Asamoa, K., Brabin, B., & Newman, R. D. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70021-x · Cited by 1,432 · cited 2×
“The burden of first trimester infections, was scarcely addressed by researchers until recent years [7] despite knowing that perturbation in early pregnancy imposes severe fetal development consequences [41,42].”
BackgroundKeeping It All Going—Complement Meets Metabolism
Kolev, M., & Kemper, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00001 · Cited by 812
An analysis of malaria in pregnancy in Africa.
Brabin, B. J. (1983) · PubMed · Cited by 782
The Impact of Placental Malaria on Gestational Age and Birth Weight
Menendez, C., Ordi, J., Ismail, M. R., Ventura, P. J., Aponte, J. J., Kahigwa, E., Font, F., & Alonso, P. L. (2000) · The Journal of Infectious Diseases · doi:10.1086/315449 · Cited by 467
Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa
Guyatt, H. L., & Snow, R. W. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.4.760-769.2004 · Cited by 458
Effects of Plasmodium vivax malaria in pregnancy.
Nosten, F., McGready, R., Simpson, J., Thwai, K., Balkan, S., Cho, T., Hkirijaroen, L., Looareesuwan, S., & White, N. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09247-2 · Cited by 381 · cited 2×
“vivax MiP outcomes is still inconclusive [16,35,36].”
BackgroundTracking placental development in health and disease
Aplin, J. D., Myers, J. E., Timms, K., & Westwood, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0372-6 · Cited by 374 · cited 1×
“The burden of first trimester infections, was scarcely addressed by researchers until recent years [7] despite knowing that perturbation in early pregnancy imposes severe fetal development consequences [41,42].”
BackgroundFried, M., Muga, R., Misore, A. O., & Duffy, P. E. (1998) · PubMed · Cited by 321
Ricke, C. H., Staalsoe, T., Koram, K., Akanmori, B. D., Riley, E. M., Theander, T. G., & Hviid, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3309 · Cited by 303
On the Cytoadhesion of Plasmodium vivax –Infected Erythrocytes
Carvalho, B. O., Lopes, S. C. P., Nogueira, P. A., Orlandi, P. P., Bargieri, D. Y., Blanco, Y. C., Mamoni, R., Leite, J. A., Rodrigues, M. M., Soares, I. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/654815 · Cited by 299 · cited 4×
“vivax proteins targeted by the immune system [14,15].”
BackgroundInfluentialSelf-citationStaalsoe, T., Shulman, C. E., Bulmer, J. N., Kawuondo, K., Marsh, K., & Hviid, L. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15386-x · Cited by 288
ROGERSON, S. J., POLLINA, E., GETACHEW, A., TADESSE, E., LEMA, V. M., & MOLYNEUX, M. E. (2003) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2003.68.1.0680115 · Cited by 275
Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance
Andrade, B. B., Reis-Filho, A., Souza-Neto, S. M., Clarêncio, J., Camargo, L. M., Barral, A., & Barral-Netto, M. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-13 · Cited by 273
Fried, M., Muga, R. O., Misore, A. O., & Duffy, P. E. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2523 · Cited by 262
Challenges for malaria elimination in Brazil
Ferreira, M. U., & Castro, M. C. (2016) · Malaria Journal · doi:10.1186/s12936-016-1335-1 · Cited by 229 · cited 1×
“vivax infections, responsible for 70–80% of total malaria cases [27,28].”
BackgroundPlacental malaria. I. Pathological classification
BULMER, J. N., RASHEED, F. N., FRANCIS, N., MORRISON, L., & GREENWOOD, B. M. (1993) · Histopathology · doi:10.1111/j.1365-2559.1993.tb00110.x · Cited by 222
Malaria in pregnancy: small babies, big problem
Umbers, A. J., Aitken, E. H., & Rogerson, S. J. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2011.01.007 · Cited by 200 · cited 2×
“Malaria in pregnancy is known to impact proper fetal development [2].”
BackgroundHoman, T., Maire, N., Hiscox, A., Di Pasquale, A., Kiche, I., Onoka, K., Mweresa, C., Mukabana, W. R., Ross, A., Smith, T. A., et al. (2016) · Malaria Journal · doi:10.1186/s12936-015-1044-1 · Cited by 187
Malaria in pregnancy and the endemicity spectrum: what can we learn?
Nosten, F., Rogerson, S. J., Beeson, J. G., McGready, R., Mutabingwa, T. K., & Brabin, B. (2004) · Trends in Parasitology · doi:10.1016/j.pt.2004.06.007 · Cited by 186 · cited 2×
“The gestational outcomes associated with MiP can vary not only with the species but also with variables such as transmission intensity and stability, number of previous pregnancies, and trimester of infection [7,37].”
BackgroundAbrams, E. T., Brown, H., Chensue, S. W., Turner, G. D. H., Tadesse, E., Lema, V. M., Molyneux, M. E., Rochford, R., Meshnick, S. R., & Rogerson, S. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2759 · Cited by 178
Incidence and admission rates for severe malaria and their impact on mortality in Africa
Camponovo, F., Bever, C. A., Galactionova, K., Smith, T., & Penny, M. A. (2017) · Malaria Journal · doi:10.1186/s12936-016-1650-6 · Cited by 178
Care-seeking patterns for fatal malaria in Tanzania.
de Savigny, D., Mayombana, C., Mwageni, E., Masanja, H., Minhaj, A., Mkilindi, Y., Mbuya, C., Kasale, H., & Reid, G. (2004) · Malaria Journal · doi:10.1186/1475-2875-3-27 · Cited by 174
McGREADY, R., DAVISON, B. B., STEPNIEWSKA, K., CHO, T., SHEE, H., BROCKMAN, A., UDOMSANGPETCH, R., LOOAREESUWAN, S., WHITE, N. J., MESHNICK, S. R., et al. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.70.398 · Cited by 170
Molecular Diagnosis of Malaria by Photo-Induced Electron Transfer Fluorogenic Primers: PET-PCR
Lucchi, N. W., Narayanan, J., Karell, M. A., Xayavong, M., Kariuki, S., DaSilva, A. J., Hill, V., & Udhayakumar, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056677 · Cited by 152 · cited 1×
“All samples collected throughout pregnancy (recruitment, malaria episodes, and domiciliary visits) and at delivery were further screened by molecular diagnosis using the real-time PCR technique (PET-PCR) as described elsewhere [13,30].”
MethodPoespoprodjo, J. R., Fobia, W., Kenangalem, E., Lampah, D. A., Warikar, N., Seal, A., McGready, R., Sugiarto, P., Tjitra, E., Anstey, N. M., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/586743 · Cited by 148
Conroy, A. L., Silver, K., Zhong, K., Rennie, M. Y., Ward, P. A., Sarma, J. V., Molyneux, M. E., Sled, J. G., Fletcher, J. F., Rogerson, S. J., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.01.010 · Cited by 141 · cited 1×
“vivax infections during pregnancy [60], and C5a is considered a hypothetical key driver of PM pathogenesis, being associated with placental insufficiency and SGA babies, and correlated negatively and positively with ANG-1 and ANG-2, respectively [61,62].”
BackgroundImpact of Malaria at the End of Pregnancy on Infant Mortality and Morbidity
Bardají, A., Sigauque, B., Sanz, S., Maixenchs, M., Ordi, J., Aponte, J. J., Mabunda, S., Alonso, P. L., & Menéndez, C. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq049 · Cited by 136
Moore, K. A., Simpson, J. A., Wiladphaingern, J., Min, A. M., Pimanpanarak, M., Paw, M. K., Raksuansak, J., Pukrittayakamee, S., Fowkes, F. J. I., White, N. J., et al. (2017) · BMC Medicine · doi:10.1186/s12916-017-0877-6 · Cited by 111 · cited 1×
“Group stratification was performed by the trimester in which the first infection occurred, considering that time of infection is known to be associated with MiP poor pregnancy outcomes [34].”
MethodVasodilator factors in the systemic and local adaptations to pregnancy
Valdés, G., Kaufmann, P., Corthorn, J., Erices, R., Brosnihan, K. B., & Joyner, J. (2009) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-7-79 · Cited by 110
Xavier-Neto, J., Carvalho, M., Pascoalino, B. D. S., Cardoso, A. C., Costa, Â. M. S., Pereira, A. H. M., Santos, L. N., Saito, Â., Marques, R. E., Smetana, J. H. C., et al. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005363 · Cited by 109
Elsaba, T. M., Martínez‐Pomares, L., Robins, A., Crook, S., Seth, R., Jackson, D., Reed, A. E. M., Silver, A. R., Tomlinson, I. P. M., & Ilyas, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010714 · Cited by 104
Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin
Ndam, N. T., Denoeud-Ndam, L., Doritchamou, J., Viwami, F., Salanti, A., Nielsen, M. A., Fievet, N., Massougbodji, A., Luty, A. J. F., & Deloron, P. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2105.141626 · Cited by 98
Nanni, P., Nicoletti, G., Palladini, A., Croci, S., Murgo, A., Ianzano, M. L., Grosso, V., Stivani, V., Antognoli, A., Lamolinara, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039626 · Cited by 93
Plasmodium vivax Adherence to Placental Glycosaminoglycans
Chotivanich, K., Udomsangpetch, R., Suwanarusk, R., Pukrittayakamee, S., Wilairatana, P., Beeson, J. G., Day, N. P. J., & White, N. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034509 · Cited by 88 · cited 4×
“vivax proteins targeted by the immune system [14,15].”
BackgroundInfluentialthe FSP/MISAME study Group, Valea, I., Tinto, H., Drabo, M. K., Huybregts, L., Sorgho, H., Ouedraogo, J.-B., Guiguemde, R. T., van Geertruyden, J. P., Kolsteren, P., et al. (2012) · Malaria Journal · doi:10.1186/1475-2875-11-71 · Cited by 87
Roy, M., Bouma, M. J., Ionides, E. L., Dhiman, R. C., & Pascual, M. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001979 · Cited by 86
Malaria, primigravidae, and antibodies: knowledge gained and future perspectives
Ataíde, R., Mayor, A. G., & Rogerson, S. J. (2014) · Trends in Parasitology · doi:10.1016/j.pt.2013.12.007 · Cited by 83
Placental malaria and its effect on pregnancy outcomes in Sudanese women from Blue Nile State
Omer, S. A., Idress, H. E., Adam, I., Abdelrahim, M., Noureldein, A. N., Abdelrazig, A. M., Elhassan, M. O., & Sulaiman, S. M. (2017) · Malaria Journal · doi:10.1186/s12936-017-2028-0 · Cited by 83
Placental Histopathological Changes Associated with Plasmodium vivax Infection during Pregnancy
Souza, R. M., Ataíde, R., Dombrowski, J. G., Ippólito, V., Aitken, E. H., Valle, S. N., Álvarez, J. M., Epiphânio, S., & Marinho, C. R. F. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002071 · Cited by 79
Self-citationDysregulation of Angiopoietins Is Associated with Placental Malaria and Low Birth Weight
Silver, K. L., Zhong, K., Leke, R. G. F., Taylor, D. W., & Kain, K. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009481 · Cited by 77
Lufele, E., Umbers, A., Ordi, J., Ome-Kaius, M., Wangnapi, R., Unger, H., Tarongka, N., Siba, P., Mueller, I., Robinson, L., et al. (2017) · Malaria Journal · doi:10.1186/s12936-017-2077-4 · Cited by 74
Nogueira, P. A., Alves, F. P., Fernández-Becerra, C., Pein, O. T., Santos, N. R., da Silva, L. P., Camargo, E. P., & Portillo, H. A. D. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.2726-2733.2006 · Cited by 73 · cited 1×
“vivax MSP119 were shown to be associated with protection against symptomatic malaria in non-pregnant individuals [63,64] and those against P.”
BackgroundBurden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study
Bardají, A., Martínez-Espinosa, F. E., Arévalo-Herrera, M., Padilla, N., Kochar, S., Ome-Kaius, M., Bôtto-Menezes, C., Castellanos, M. E., Kochar, D. K., Kochar, S. K., et al. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005606 · Cited by 72
Fried, M., Kurtis, J. D., Swihart, B., Pond-Tor, S., Barry, A., Sidibe, Y., Gaoussou, S., Traore, M., Keita, S., Mahamar, A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix623 · Cited by 71
Yeo, T. W., Lampah, D. A., Tjitra, E., Piera, K., Gitawati, R., Kenangalem, E., Price, R. N., & Anstey, N. M. (2010) · The Journal of Infectious Diseases · doi:10.1086/653211 · Cited by 70 · cited 1×
“vivax infections are most likely a consequence of systemic inflammation and production of cytokines [19], such as TNF-α and IFN-γ, which are linked to disease severity, or IL-10 that is associated with better disease prognosis [20].”
BackgroundPREGNANCY OUTCOMES ASSOCIATED WITH PLASMODIUM VIVAX MALARIA IN NORTHEASTERN VENEZUELA
RODRIGUEZ-MORALES, A. J., SANCHEZ, E., VARGAS, M., PICCOLO, C., COLINA, R., ARRIA, M., & FRANCO-PAREDES, C. (2006) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.755 · Cited by 68 · cited 1×
“vivax is more prevalent, gravidity-dependent immunity acquisition is uncertain and inconsistently reported [8,16,35,39].”
BackgroundPincelli, A., Neves, P. A. R., Lourenço, B. H., Corder, R. M., Malta, M. B., Sampaio-Silva, J., de Souza, R. M., Cardoso, M. A., Castro, M. C., Ferreira, M. U., et al. (2018) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.18-0135 · Cited by 57 · cited 2×
“vivax MiP outcomes is still inconclusive [16,35,36].”
BackgroundSelf-citationPlacental Infection With Plasmodium vivax: A Histopathological and Molecular Study
Mayor, A., Bardají, A., Felger, I., King, C. L., Cisteró, P., Dobaño, C., Stanisic, D. I., Siba, P., Wahlgren, M., del Portillo, H., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis614 · Cited by 53 · cited 1×
“vivax monoinfections do not promote placental inflammation and that adverse outcomes have an alternative etiologic nature [55].”
BackgroundMayor, A., Rovira-Vallbona, E., Machevo, S., Bassat, Q., Aguilar, R., Quintó, L., Jiménez, A., Sigauque, B., Dobaño, C., Kumar, S., et al. (2011) · Infection and Immunity · doi:10.1128/iai.01000-10 · Cited by 46
Odhiambo, F. O., Buff, A. M., Morang’a, C. M., Moseti, C., Wesongah, J. O., Lowther, S. A., Arvelo, W., Galgalo, T., Achia, T., Roka, Z. G., et al. (2017) · Malaria Journal · doi:10.1186/s12936-017-2018-2 · Cited by 46
Carmona-Fonseca, J., Arango, E., & Maestre, A. (2013) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.12-0363 · Cited by 42
Bastos, M. S., da Silva‐Nunes, M., Malafronte, R. S., Hoffmann, E. H. E., Wunderlich, G., Moraes, S. L., & Ferreira, M. U. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00243-07 · Cited by 38 · cited 1×
“25 ng/ well), produced as described elsewhere [32,33].”
Self-citationMalaria in Pregnancy Interacts with and Alters the Angiogenic Profiles of the Placenta
Ataíde, R., Murillo, O., Dombrowski, J. G., Souza, R. M., Lima, F. A., Lima, G. F. M. C., Hristov, A. D., Valle, S. C. N., Di Santi, S. M., Epiphanio, S., et al. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0003824 · Cited by 37 · cited 2×
“vivax-induced inflammation during pregnancy may be implicated in placental structural abnormalities and leukocytes infiltration, as well as in angiogenic imbalance, which altogether can directly or indirectly impact fetal development [11,13,21].”
BackgroundMethodSelf-citationLeijnse, J. E. W., de Heus, R., de Jager, W., Rodenburg, W., Peeters, L. L. H., Franx, A., & Eijkelkamp, N. (2018) · Pregnancy Hypertension · doi:10.1016/j.preghy.2018.04.008 · Cited by 37
Antigenic properties of the merozoite surface protein 1 gene of Plasmodium vivax
de Oliveira, C. I., Wunderlich, G., Levitus, G., Soares, I. S., Rodrigues, M. M., Tsuji, M., & Portillo, H. A. D. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00176-0 · Cited by 35 · cited 1×
“25 ng/ well), produced as described elsewhere [32,33].”
Self-citationPlasmodium vivax Malaria during Pregnancy, Bolivia
Brutus, L., Santalla, J., Schneider, D., Avila, J. C., & Deloron, P. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1910.130308 · Cited by 34
Wang, Q., Zhao, Z., Zhang, X., Li, X., Zhu, M., Li, P., Yang, Z., Wang, Y., Yan, G., Shang, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151900 · Cited by 34 · cited 1×
“vivax MSP119 were shown to be associated with protection against symptomatic malaria in non-pregnant individuals [63,64] and those against P.”
BackgroundGomes, L. T., Alves, E. R., Mendes, C. R. D. J., Nery, A. F., Martin, T. O. G., & Fontes, C. J. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109246 · Cited by 31
Dombrowski, J. G., Souza, R. M. D., Lima, F. A., Bandeira, C. L., Murillo, O., Costa, D. D. S., Peixoto, E. P. M., Cunha, M. D. P., Zanotto, P. M. D. A., Bevilacqua, E., et al. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.3300 · Cited by 31 · cited 6×
“All histological evaluation methods were optimized by our group and are described elsewhere [11,13].”
BackgroundMethodInfluentialSelf-citationSpatial and spatio-temporal analysis of malaria in the state of Acre, western Amazon, Brazil
Melchior, L. A. K., & Neto, F. C. (2016) · Geospatial health · doi:10.4081/gh.2016.443 · Cited by 29 · cited 1×
“vivax infections, responsible for 70–80% of total malaria cases [27,28].”
BackgroundOgbu, G. I., Aimakhu, C., Anzaku, A. S., Ngwan, S. D., & Ogbu, D. A. (2015) · Journal of Reproductive Biology and Health · doi:10.7243/2054-0841-3-1 · Cited by 28 · cited 1×
“described in other studies [46,47], we hypothesize that inflammation modulation during pregnancy might favor parasite multiplication and relapses.”
ResultCytokine signatures of Plasmodium vivax infection during pregnancy and delivery outcomes
Dobaño, C., Bardají, A., Arévalo-Herrera, M., Martínez-Espinosa, F. E., Bôtto-Menezes, C., Padilla, N., Menegon, M., Kochar, S., Kochar, S. K., Unger, H., et al. (2020) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0008155 · Cited by 28 · cited 2×
“vivax malaria during pregnancy that are lost at delivery [60].”
BackgroundComplement activation: a critical mediator of adverse fetal outcomes in placental malaria?
Conroy, A. L., McDonald, C. R., Silver, K. L., Liles, W. C., & Kain, K. C. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2011.02.005 · Cited by 26 · cited 1×
“vivax infections during pregnancy [60], and C5a is considered a hypothetical key driver of PM pathogenesis, being associated with placental insufficiency and SGA babies, and correlated negatively and positively with ANG-1 and ANG-2, respectively [61,62].”
BackgroundEffects of Vivax Malaria Acquired Before 20 Weeks of Pregnancy on Subsequent Changes in Fetal Growth
Machado Filho, A. C., da Costa, E. P., da Costa, E. P., Reis, I. S., Fernandes, E. A. C., Paim, B. V., & Martinez-Espinosa, F. E. (2014) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0285 · Cited by 26 · cited 2×
“vivax MiP outcomes is still inconclusive [16,35,36].”
BackgroundRequena, P., Rui, E., Padilla, N., Martínez-Espinosa, F. E., Castellanos, M. E., Bôtto-Menezes, C., Malheiro, A., Arévalo-Herrera, M., Kochar, S., Kochar, S. K., et al. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005009 · Cited by 24 · cited 1×
“vivax [65,66], suggesting that targeting non-pregnancy related antigens may also improve gestational outcomes.”
BackgroundTobón-Castaño, A., Solano, M. A., Sánchez, L. G. Á., & Trujillo, S. B. (2011) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822011005000030 · Cited by 21 · cited 5×
“Malaria in Brazil represents one of the highest percentages of Latin America cases, where approximately 84% of infections are attributed to Plasmodium (P.) vivax.”
ResultInfluentialImpact of Malaria in Pregnancy as Latin America Approaches Elimination
Yanow, S. K., Gavina, K., Gnidehou, S., & Maestre, A. (2016) · Trends in Parasitology · doi:10.1016/j.pt.2016.01.008 · Cited by 20 · cited 2×
“malaria transmission may impair immunity acquisition across pregnancies [8,37].”
BackgroundNassif, C., Gomes, A. R., Peixoto, G. H. C., Chagas, M. H., Soares, D. D., Garcia, E. S., Drinkwater, E. J., Cannon, J., & Marino, F. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104710 · Cited by 19
Post-exposure serological responses to malaria parasites in potential blood donors
Portugal-Calisto, D., Ferreira, A. R., Silva, M. S., & Teodósio, R. M. F. (2016) · Malaria Journal · doi:10.1186/s12936-016-1586-x · Cited by 18
Placental malaria, anaemia and low birthweight in Yemen
Albiti, A. H., Adam, I., & Ghouth, A. S. B. (2009) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/j.trstmh.2009.07.004 · Cited by 16
Requena, P., Arévalo-Herrera, M., Menegon, M., Martínez-Espinosa, F. E., Padilla, N., Bôtto-Menezes, C., Malheiro, A., Hans, D., Castellanos, M. E., Robinson, L., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00163 · Cited by 13
de Souza, R. M., AtaÃde, R., Dombrowski, J. G., Ippólito, Aitken, E. H., do Valle, S. D. C. N., Álvarez, J. M., Epiphânio, S., & Marinho, C. R. F. (2013) · PLoS neglected tropical diseases · doi:10.1371/annotation/28901e80-13ad-4cae-99e8-8d54625743b6 · Cited by 10 · cited 4×
“vivax-induced inflammation during pregnancy may be implicated in placental structural abnormalities and leukocytes infiltration, as well as in angiogenic imbalance, which altogether can directly or indirectly impact fetal development [11,13,21].”
BackgroundMethodInfluentialSelf-citationMalária em gestantes no município de Cruzeiro do Sul pertencente à região amazônica brasileira
do Valle, S. D. C. N. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2011.tde-16042012-164631 · Cited by 3 · cited 5×
“Malaria in Brazil represents one of the highest percentages of Latin America cases, where approximately 84% of infections are attributed to Plasmodium (P.) vivax.”
ResultInfluential
Research works printed but not linked: 2
- Brazil. Ministry of Health. Secretariat of Health Surveillance. Department of Epidemiological Surveillance, 2010, Malaria’s treatment in Brazil practical guide. Brazilian Ministry of Health, Departamento de Vigilância Epidemiológica—Secretaria de Vigilância em Saúde
- WHO, 2015, Guidelines for the treatment of malaria
Cited by
Pathogenicity and virulence of malaria: Sticky problems and tricky solutions
Walker, I. S., & Rogerson, S. J. (2022) · Virulence · doi:10.1080/21505594.2022.2150456 · Cited by 70
“pregnancy is less well studied but has also been associated with preterm birth and low birthweight [341,342].”
BackgroundCurrent update on malaria in pregnancy: a systematic review
Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G. (2025) · Tropical Diseases, Travel Medicine and Vaccines · doi:10.1186/s40794-025-00248-1 · Cited by 49
“Additionally, a study conducted in Brazil by Dombrowski et al. (2021) found that IgG against the P.vivax MSP 119 protein was used as a marker for exposure during pregnancy [96].”
The biology and pathogenesis of vivax malaria
Anstey, N. M., Tham, W., Shanks, G. D., Poespoprodjo, J. R., Russell, B., & Kho, S. (2024) · Trends in Parasitology · doi:10.1016/j.pt.2024.04.015 · Cited by 38
Adverse pregnancy outcomes in maternal malarial infection: A systematic review and meta-analysis
Satapathy, P., Khatib, M. N., Gaidhane, S., Zahiruddin, Q. S., Sharma, R. K., Rustagi, S., Al-Jishi, J. M., Albayat, H., Fares, M. A. A., Garout, M. A., et al. (2024) · New Microbes and New Infections · doi:10.1016/j.nmni.2024.101474 · Cited by 40
“Studies were conducted in a variety of locations, including Uganda [28 – 30], Ethiopia [31,32], Brazil [33 – 35], Cameroon [19,36 – 38], Ghana [39,40], Gabon [41,42], India [43 – 46], Thailand [47,48], the Democratic Republic of the Congo [49], Zimbabwe [50,51], Malawi [52], Tanzania [53], Colombia…”
BackgroundNana, R. R. D., Hawadak, J., Foko, L. P. K., Kumar, A., Chaudhry, S., Arya, A., & Singh, V. (2022) · Pathogens and Global Health · doi:10.1080/20477724.2022.2128563 · Cited by 39
“3) Pv [46] Colombia 2014 – 2015 180 (25.”
Metadata
- Authors
- Dombrowski, J. G., Barateiro, A., Peixoto, E. P. M., Barros, A. B. C. D. S., Souza, R. M. D., Clark, T. G., Campino, S., Wrenger, C., Wunderlich, G., Palmisano, G., Epiphanio, S., Gonçalves, L. A., & Marinho, C. R. F.
- Affiliations
- Universidade de São Paulo (BR)
- Instituto Gulbenkian de Ciência (PT)
- Universidade Federal do Acre (BR)
- London School of Hygiene & Tropical Medicine (GB)
- Corresponding author
- Dombrowski, Jamille Gregório
- Barateiro, André
- Peixoto, Erika Paula Machado
- Barros, André Boler Cláudio da Silva
- Souza, Rodrigo Medeiros de
- Clark, Taane Gregory
- Campino, Susana
- Wrenger, Carsten
- Wunderlich, Gerhard
- Palmisano, Giuseppe
- Gonçalves, Lígia Antunes
- ORCID
- Venue
- PLOS Neglected Tropical Diseases
- Publisher
- Public Library of Science (PLoS)
- Published
- 2021-04-29
- Volume
- 15
- Issue
- 4
- Pages
- e0009390
- ISSN
- 1935-2727 (ISSN-L)
- 1935-2735
- PMC
- PMC8112668
- OpenAlex
- W3158909516
- Cited by
- 42
- References
- 77
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 13 · 2023: 6 · 2022: 8 · 2021: 5
- FWCI
- 6.92
- Type
- journal article
- Language
- en
- Update notices
- new_version (2021-05-11)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS neglected tropical diseases (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/20468-0; 2020/06747-4, 2017/05782-8, 2015/26722-8; 2017/03966-4, 2017/24267-7, 2018/18257-1; 2018/15549-1; 2020/04923-0, 2019/12068-5, 2017/03939-7)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (409216/2018-6)
- Medical Research Council United Kingdom (MR/M01360X/1; MR/N010469/1; MR/R025576/1; MR/R020973/1, MR/M01360X/1; MR/R025576/1; MR/R020973/1)
- Fundação para a Ciência e a Tecnologia (PD/BD/138900/2018)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Keywords
- Plasmodium vivax, malaria in pregnancy, adverse pregnancy outcomes, preterm birth, fetal head circumference, placental pathology, angiopoietin-2, C5a, angiogenic imbalance, first trimester, maternal and fetal health, Brazilian Amazon
- MeSH terms
- Adolescent, Adult, Antigens, Protozoan, Brazil, Female, Humans, Immunoglobulin G, Infant, Newborn, Placenta, Plasmodium vivax, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Pregnancy Trimester, First, Prospective Studies, Multivariate Analysis, Logistic Models, Malaria, Falciparum, Malaria, Vivax, Premature Birth, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.